Efficacy and Safety of Semaglutide Once Weekly Versus Insulin Glargine Once Daily as Add on to Metformin With or Without Sulphonylurea in Insulin-naïve Subjects With Type 2 Diabetes
Efficacy and Safety of Semaglutide Once Weekly Versus Insulin Glargine Once Daily as Add on to Metformin With or Without Sulphonylurea in Insulin-naïve Subjects With Type 2 Diabetes
This trial is conducted in Africa, North and South America, Asia and Europe. The purpose of the trial is to compare the effect of once-weekly dosing of two dose levels of semaglutide versus insulin glargine once-daily on glycaemic control after 30 weeks of treatment in insulin-naïve subjects with type 2 diabetes.
Inclusion Criteria:
Exclusion Criteria:
CABA, C1119ACN, Argentina
Capital Federal, C1056ABJ, Argentina
Marseille Cédex 05, 13385, France
Trinité - La Martinique, 97235, France
Saint Ingbert-Oberwürzbach, 66386, Germany
New Dehli, New Delhi 110029, India
México D.F., México, D.F. 11550, Mexico
Harrogate, North Yorkshire, HG2 7SX, United Kingdom